News

By Priscila Mayumi Kashiwabara

September 23, 2024

Priscila Kashiwabara will be attending “From Gene to Trait 2024” course

Our partner Priscila Kashiwabara will be one of the speakers at the “From Gene to Trait 2024” course. The event will take Priscila Kashiwabara will be attending “From Gene to Trait 2024” course

Ler notícia

August 7, 2024

We were remembered by the Life Sciences Awards 2024 Americas and it is coming!

Our partner Priscila Kashiwabara has been pre-selected as a finalist in the Life Sciences Awards 2024 Americas. Our office has also been We were remembered by the Life Sciences Awards 2024 Americas and it is coming!

Ler notícia

July 2, 2024

Life Sciences’ Brazil Global Guide 2024 is now available

We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide! Our partners Priscila Kashiwabara Life Sciences’ Brazil Global Guide 2024 is now available

Ler notícia

May 24, 2024

New WIPO Treaty on Genetic Resources and Associated Traditional Knowledge Approved

Member states of the World Intellectual Property Organization (WIPO) have approved a groundbreaking treaty that addresses the intersection between intellectual property, more New WIPO Treaty on Genetic Resources and Associated Traditional Knowledge Approved

Ler notícia

November 17, 2023

Article “How to patent biological materials from 3D printing” for LSIPR

The article “How to patent biological materials from 3D printing,” written by our partner Priscila Kashiwabara and patent specialist Breno Souza, has Article “How to patent biological materials from 3D printing” for LSIPR

Ler notícia

October 26, 2023

Kasznar Leonardos represented at the AIPPI World Congress 2023

We, from Kasznar Leonardos, were represented at the AIPPI World Conference held in Istanbul, Turkey. Our partners, João Luís Vianna, Gabriel Leonardos, Kasznar Leonardos represented at the AIPPI World Congress 2023

Ler notícia

October 9, 2023

Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

Ler notícia

October 3, 2023

Brazil climbs five positions and reaches Top 50 in WIPO’S Global Innovation Index 2023 Ranking

The World Intellectual Property Organization (WIPO) has just published this year’s edition of its Global Innovation Index (GII). Among the 132 economies included in Brazil climbs five positions and reaches Top 50 in WIPO’S Global Innovation Index 2023 Ranking

Ler notícia

September 14, 2023

On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”,  published on IAM Media, authored by On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

Ler notícia
plugins premium WordPress